EF-M2 (Immutalon) Multiple Ascending Dose Study in Moderate-to-Severe Rheumatoid Arthritis

Clinical trial NCT07349420 · COMPLETED

Trial details

NCT number: NCT07349420
Sponsor: S.LAB (SOLOWAYS)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2025-06-03
Primary completion: 2025-10-05
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.